Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 18:4:110.
doi: 10.3389/fcell.2016.00110. eCollection 2016.

Roles of FGF Signals in Heart Development, Health, and Disease

Affiliations
Review

Roles of FGF Signals in Heart Development, Health, and Disease

Nobuyuki Itoh et al. Front Cell Dev Biol. .

Abstract

The heart provides the body with oxygen and nutrients and assists in the removal of metabolic waste through the blood vessels of the circulatory system. It is the first organ to form during embryonic morphogenesis. FGFs with diverse functions in development, health, and disease are signaling proteins, mostly as paracrine growth factors or endocrine hormones. The human/mouse FGF family comprises 22 members. Findings obtained from mouse models and human diseases with FGF signaling disorders have indicated that several FGFs are involved in heart development, health, and disease. Paracrine FGFs including FGF8, FGF9, FGF10, and FGF16 act as paracrine signals in embryonic heart development. In addition, paracrine FGFs including FGF2, FGF9, FGF10, and FGF16 play roles as paracrine signals in postnatal heart pathophysiology. Although FGF15/19, FGF21, and FGF23 are typical endocrine FGFs, they mainly function as paracrine signals in heart development or pathophysiology. In heart diseases, serum FGF15/19 levels or FGF21 and FGF23 levels decrease or increase, respectively, indicating their possible roles in heart pathophysiology. FGF2 and FGF10 also stimulate the cardiac differentiation of cultured stem cells and cardiac reprogramming of cultured fibroblasts. These findings provide new insights into the roles of FGF signaling in the heart and potential therapeutic strategies for cardiac disorders.

Keywords: FGF; biomarker; development; differentiation; disease; heart.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms of action of paracrine and endocrine FGFs. (A) Paracrine FGFs specifically bind to the FGFR-heparan sulfate complex and activate FGFR tyrosine kinase. Endocrine FGFs specifically bind to the FGFR-Klotho complex and activate tyrosine kinase. This, in turn, induces the activation of intracellular pathways (Ornitz and Itoh, ; Brewer et al., 2016). (B) Paracrine FGFs are secreted local signals that act on nearby target cells by diffusion with functions in multiple developmental and pathophysiological processes. Endocrine FGFs are secreted endocrine signals that act on distant target cells through the bloodstream with multiple functions in metabolic and pathophysiological processes. FGFR-HS and FGFR-Klotho indicate the FGFR-heparan sulfate complex and FGFR-Klotho complex, respectively (Ornitz and Itoh, ; Brewer et al., 2016).
Figure 2
Figure 2
Evolutionary relationships within the human FGF family. Phylogenetic analyses suggest that 22 members of the FGF family are classified into several subfamilies. Branch lengths are proportional to the evolutionary distance between each FGF. FGFs are also classified into paracrine, endocrine, and intracrine FGFs based on their mechanisms of action (Ornitz and Itoh, ; Brewer et al., 2016). FGF2, FGF3, FGF8, FGF9, FGF10, FGF15/19, FGF16, FGF21, and FGF23 play roles in heart development, health, and disease. This figure is adapted from Itoh et al. (2016).

Similar articles

Cited by

References

    1. Ables G. P., Ouattara A., Hampton T. G., Cooke D., Perodin F., Augie I., et al. . (2015). Dietary methionine restriction in mice elicits an adaptive cardiovascular response to hyperhomocysteinemia. Sci. Rep. 5:8886. 10.1038/srep08886 - DOI - PMC - PubMed
    1. Abu-Issa R., Smyth G., Smoak I., Yamamura K., Meyers E. N. (2002). Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129, 4613–4625. - PubMed
    1. Andersen I. A., Huntley B. K., Sandberg S. S., Heublein D. M., Burnett J. C., Jr. (2016). Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure. Nephrol. Dial. Transplant. 31, 767–772. 10.1093/ndt/gfv398 - DOI - PubMed
    1. Brewer J. R., Mazot P., Soriano P. (2016). Genetic insights into the mechanisms of Fgf signaling. Genes Dev. 30, 751–771. 10.1101/gad.277137.115 - DOI - PMC - PubMed
    1. Carter E. P., Fearon A. E., Grose R. P. (2015). Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol. 25, 221–233. 10.1016/j.tcb.2014.11.003 - DOI - PubMed